Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: FTSE 100 on track for fourth straight loss

Wed, 17th Apr 2013 11:39

A number of heavyweight stocks going ex-dividend assured that London's FTSE 100 index was in the red for a fourth consecutive day on Wednesday, while concerns over the global economy continued to weigh on sentiment.Global growth fears have hit markets over the last few days after a surprise slowdown was reported in China in the first quarter. These concerns were compounded yesterday when the International Monetary Fund (IMF) revised lower its forecasts for global economic growth, cutting estimates for the UK, US, Eurozone and China.Unconfirmed rumours of a German credit rating downgrade were also giving investors more reasons to be cautious this morning, as well as the UK unemployment rate rising from 7.8% to 7.9% in the three months to February.The minutes from the latest Bank of England's Monetary Policy Committee (MPC) meeting released today showed that policymakers were split six to three in favour of maintaining the asset purchase programme at £375bn, as expected. They voted unanimously to keep the Bank Rate at 0.5%.For Barclays Research, today's minutes confirm its view that the redrafted MPC remit included in the March Budget does not give the committee greater leeway to focus on stimulating the economy. In that same vein, analysts point out that should activity stabilise, afterwards returning to growth while inflation stays high, then a majority of the MPC will not vote to increase quantitative easing (QE). However, they said that "it would take relatively little bad news on demand to propel the committee into a further QE push".US indices performed well last night after Goldman Sachs joined a growing list of companies to report better-than-expected earnings. Banking peers Citigroup, Wells Fargo and JPMorgan Chase have all beaten forecasts with their first-quarter results in the past week. Futures Stateside are pointing to a weak start ahead of earnings from Bank of America ahead of the opening bell.FTSE 100: Ex-div stocks provide a dragA number of heavyweight constituents went ex-dividend this morning, meaning that new investors will not be able to get their hands on the latest dividend payments. These companies included: ARM, BAE Systems, BG Group, Capita, Fresnillo, Petrofac, Resolution, Smith & Nephew, Tullow Oil and Wood Group.Iconic British luxury brand Burberry gained after reporting a 9.0% rise in underlying revenue in the second half as strong growth in Retail continued to offset a weaker performance in Wholesale.BHP Billiton, one of the world's largest miners, fell despite confirming that it was on track to hit full-year targets despite a lacklustre quarter.Tesco was also lower after posting its first decline in annual profits in two decades. The supermarket giant reported an underlying pre-tax profit of £3.5bn in the year to February 23rd 2013, a 10.7% fall from the £3.92bn the previous year.Financial services group Hargreaves Lansdown was making gains after saying that assets under administration reached record levels in the last three months as investor confidence continues to improve.FTSE 250: Hikma goes ex-div, decides not to sell injectablesHikma Pharmaceuticals was a heavy faller today after going ex-dividend, along with others including Chemring, Rentokil, Taylor Wimpey and Spirax-Sarco Engineering. Hikma also announced that it has decided not to sell its global injectables business despite significant interest.Hochschild Mining fell after reporting a fall in silver production and sales for the first quarter. Silver production came to 4.3m ounces in the three months to March 31st, down from 4.77m in the previous quarter and 4.76m a year earlier. Petra Diamond was heading the other way after discovering a 25.5 carat blue diamond at the Cullinan mine in South Africa. The rare stone is considered to be a high quality gem diamond of top colour. FTSE 100 - RisersBurberry Group (BRBY) 1,320.00p +4.27%Hargreaves Lansdown (HL.) 936.50p +4.06%ARM Holdings (ARM) 890.50p +2.59%Carnival (CCL) 2,291.00p +1.73%Centrica (CNA) 381.40p +1.36%Severn Trent (SVT) 1,759.00p +1.21%International Consolidated Airlines Group SA (CDI) (IAG) 252.40p +1.16%Diageo (DGE) 1,983.00p +1.15%Rolls-Royce Holdings (RR.) 1,127.00p +1.08%BT Group (BT.A) 277.20p +1.02%FTSE 100 - FallersFresnillo (FRES) 1,088.00p -6.29%Resolution Ltd. (RSL) 258.70p -6.27%Evraz (EVR) 157.30p -5.18%BAE Systems (BA.) 375.60p -3.72%Polymetal International (POLY) 719.50p -3.29%Petrofac Ltd. (PFC) 1,297.00p -3.21%Tesco (TSCO) 372.50p -3.21%BG Group (BG.) 1,047.00p -2.97%Prudential (PRU) 1,026.00p -2.56%Weir Group (WEIR) 2,158.00p -2.53%FTSE 250 - RisersSpirent Communications (SPT) 126.90p +3.34%Savills (SVS) 525.50p +2.64%Laird (LRD) 212.60p +2.46%Marston's (MARS) 135.30p +2.19%Synthomer (SYNT) 182.60p +2.18%St James's Place (STJ) 494.40p +1.79%Domino's Pizza Group (DOM) 622.50p +1.72%Rank Group (RNK) 157.60p +1.68%Hiscox Ltd. (HSX) 548.00p +1.67%Premier Farnell (PFL) 205.00p +1.49%FTSE 250 - FallersFerrexpo (FXPO) 163.50p -5.82%Hikma Pharmaceuticals (HIK) 935.00p -5.08%Perform Group (PER) 473.50p -4.61%SVG Capital (SVI) 369.40p -4.50%Lonmin (LMI) 263.10p -4.22%Beazley (BEZ) 204.80p -3.67%Kazakhmys (KAZ) 333.90p -3.41%BlackRock World Mining Trust (BRWM) 489.00p -2.88%SDL (SDL) 408.00p -2.83%Mondi (MNDI) 837.00p -2.73%BC
More News
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.